Ozempic may lower the risk of serious complications from chronic kidney disease. Medical providers break down the latest research and potential links.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to taking Ozempic: It may help manage chronic kidney disease (CKD). On ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

Discover the serious yet rare side effects of Ozempic, including pancreatitis, thyroid cancer, gallbladder issues, kidney injury, and allergic reactions, plus expert insights.

People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...